Compounds > rofecoxib
Page last updated: 2024-11-04

rofecoxib and Colitis, Ischemic

rofecoxib has been researched along with Colitis, Ischemic in 1 studies

Colitis, Ischemic: Inflammation of the COLON due to colonic ISCHEMIA resulting from alterations in systemic circulation or local vasculature.

Research Excerpts

ExcerptRelevanceReference
"Rofecoxib is a selective cyclooxygenase-2 inhibitor that has been approved for the treatment of osteoarthritis and management of acute pain."1.33Ischemic colitis associated with rofecoxib. ( Feltri, M; Meucci, G; Minoli, G; Radaelli, F; Spinzi, G; Terruzzi, V, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Radaelli, F1
Feltri, M1
Meucci, G1
Spinzi, G1
Terruzzi, V1
Minoli, G1

Other Studies

1 other study available for rofecoxib and Colitis, Ischemic

ArticleYear
Ischemic colitis associated with rofecoxib.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:5

    Topics: Abdominal Pain; Colitis, Ischemic; Colon; Cyclooxygenase Inhibitors; Female; Gastrointestinal Hemorr

2005